Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel F Berkovic

Showing results (121-130 of 464) with videos related to

Pageof 47
Sort By:
Epilepsia|January 23, 2014
Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trialVictor Biton, Samuel F Berkovic, Bassel Abou-Khalil, et al.
Human Mutation|May 10, 2005
SCN1A mutations and epilepsyJohn C Mulley, Ingrid E Scheffer, Steven Petrou, et al.
Cerebral Cortex (New York, N.Y. : 1991)|July 7, 2007
Intracortical hyperexcitability in humans with a GABAA receptor mutationMarco Fedi, Samuel F Berkovic, Richard A L Macdonell, et al.
Epilepsia|April 9, 2022
Rare sudden unexpected death in epilepsy SCN5A variants cause changes in channel function implicating cardiac arrhythmia as a cause of deathMing S Soh, Richard D Bagnall, Christopher Semsarian, et al.
Archives of Neurology|June 15, 2011
Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathyLeanne M Dibbens, Ioannis Karakis, Marta A Bayly, et al.
Annals of Neurology|February 27, 2010
Predicting seizure control: cortical excitability and antiepileptic medicationRadwa A B Badawy, Richard A L Macdonell, Samuel F Berkovic, et al.
Neurology|February 15, 2013
Multiple molecular mechanisms for a single GABAA mutation in epilepsyChristopher A Reid, Taehwan Kim, A Marie Phillips, et al.
Epilepsy Research|February 14, 2017
SCN1A clinical spectrum includes the self-limited focal epilepsies of childhoodSara Kivity, Karen L Oliver, Zaid Afawi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2007
Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone releaseMarco Fedi, Leon A Bach, Samuel F Berkovic, et al.
British Journal of Pharmacology|October 25, 2016
Synaptic Zn<sup>2</sup><sup>+</sup> and febrile seizure susceptibilityChristopher A Reid, Michael S Hildebrand, Saul A Mullen, et al.
Pageof 47

Showing results (121-130 of 464) with videos related to

Sort By:
Pageof 47
Epilepsia|January 23, 2014
Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trialVictor Biton, Samuel F Berkovic, Bassel Abou-Khalil, et al.
Human Mutation|May 10, 2005
SCN1A mutations and epilepsyJohn C Mulley, Ingrid E Scheffer, Steven Petrou, et al.
Cerebral Cortex (New York, N.Y. : 1991)|July 7, 2007
Intracortical hyperexcitability in humans with a GABAA receptor mutationMarco Fedi, Samuel F Berkovic, Richard A L Macdonell, et al.
Epilepsia|April 9, 2022
Rare sudden unexpected death in epilepsy SCN5A variants cause changes in channel function implicating cardiac arrhythmia as a cause of deathMing S Soh, Richard D Bagnall, Christopher Semsarian, et al.
Archives of Neurology|June 15, 2011
Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathyLeanne M Dibbens, Ioannis Karakis, Marta A Bayly, et al.
Annals of Neurology|February 27, 2010
Predicting seizure control: cortical excitability and antiepileptic medicationRadwa A B Badawy, Richard A L Macdonell, Samuel F Berkovic, et al.
Neurology|February 15, 2013
Multiple molecular mechanisms for a single GABAA mutation in epilepsyChristopher A Reid, Taehwan Kim, A Marie Phillips, et al.
Epilepsy Research|February 14, 2017
SCN1A clinical spectrum includes the self-limited focal epilepsies of childhoodSara Kivity, Karen L Oliver, Zaid Afawi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2007
Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone releaseMarco Fedi, Leon A Bach, Samuel F Berkovic, et al.
British Journal of Pharmacology|October 25, 2016
Synaptic Zn<sup>2</sup><sup>+</sup> and febrile seizure susceptibilityChristopher A Reid, Michael S Hildebrand, Saul A Mullen, et al.
Pageof 47